Cargando…
Utilizing MiSeq Sequencing to Detect Circulating microRNAs in Plasma for Improved Lung Cancer Diagnosis
Non-small cell lung cancer (NSCLC) is a major contributor to cancer-related deaths, but early detection can reduce mortality. NSCLC comprises mainly adenocarcinoma (AC) and squamous cell carcinoma (SCC). Circulating microRNAs (miRNAs) in plasma have emerged as promising biomarkers for NSCLC. However...
Autores principales: | Geng, Xinyan, Tsou, Jen-Hui, Stass, Sanford A., Jiang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299334/ https://www.ncbi.nlm.nih.gov/pubmed/37373422 http://dx.doi.org/10.3390/ijms241210277 |
Ejemplares similares
-
Evaluation of the reproducibility of amplicon sequencing with Illumina MiSeq platform
por: Wen, Chongqing, et al.
Publicado: (2017) -
Illumina MiSeq sequencing analysis of fungal diversity in stored dates
por: Al-Bulushi, Ismail M., et al.
Publicado: (2017) -
Perspectives of using Illumina MiSeq for identification
of arbuscular mycorrhizal fungi
por: Kryukov, A.A., et al.
Publicado: (2020) -
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
por: Caporaso, J Gregory, et al.
Publicado: (2012) -
Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing
por: Lange, Vinzenz, et al.
Publicado: (2014)